Literature DB >> 26109254

Gene transfer engineering for astrocyte-specific silencing in the CNS.

N Merienne1,2, A Delzor3,4, A Viret1,2, N Dufour3,4, M Rey1,2, P Hantraye3,4, N Déglon1,2.   

Abstract

Cell-type-specific gene silencing is critical to understand cell functions in normal and pathological conditions, in particular in the brain where strong cellular heterogeneity exists. Molecular engineering of lentiviral vectors has been widely used to express genes of interest specifically in neurons or astrocytes. However, we show that these strategies are not suitable for astrocyte-specific gene silencing due to the processing of small hairpin RNA (shRNA) in a cell. Here we develop an indirect method based on a tetracycline-regulated system to fully restrict shRNA expression to astrocytes. The combination of Mokola-G envelope pseudotyping, glutamine synthetase promoter and two distinct microRNA target sequences provides a powerful tool for efficient and cell-type-specific gene silencing in the central nervous system. We anticipate our vector will be a potent and versatile system to improve the targeting of cell populations for fundamental as well as therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26109254     DOI: 10.1038/gt.2015.54

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  39 in total

Review 1.  Genetic approaches to study glial cells in the rodent brain.

Authors:  Frank W Pfrieger; Michal Slezak
Journal:  Glia       Date:  2011-12-07       Impact factor: 7.452

2.  A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.

Authors:  Kum-Joo Shin; Estelle A Wall; Joelle R Zavzavadjian; Leah A Santat; Jamie Liu; Jong-Ik Hwang; Robert Rebres; Tamara Roach; William Seaman; Melvin I Simon; Iain D C Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

3.  Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus.

Authors:  A F Hottinger; M Azzouz; N Déglon; P Aebischer; A D Zurn
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

4.  Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.

Authors:  Deborah J Watson; Gary P Kobinger; Marco A Passini; James M Wilson; John H Wolfe
Journal:  Mol Ther       Date:  2002-05       Impact factor: 11.454

5.  Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.

Authors:  E Régulier; L Pereira de Almeida; B Sommer; P Aebischer; N Déglon
Journal:  Hum Gene Ther       Date:  2002-11-01       Impact factor: 5.695

6.  GFAP Transgenic Mice

Authors: 
Journal:  Methods       Date:  1996-12       Impact factor: 3.608

7.  Sustained effects of nonallele-specific Huntingtin silencing.

Authors:  Valérie Drouet; Valérie Perrin; Raymonde Hassig; Noëlle Dufour; Gwennaelle Auregan; Sandro Alves; Gilles Bonvento; Emmanuel Brouillet; Ruth Luthi-Carter; Philippe Hantraye; Nicole Déglon
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

8.  A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.

Authors:  Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

9.  A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice.

Authors:  Brian D Brown; Alessio Cantore; Andrea Annoni; Lucia Sergi Sergi; Angelo Lombardo; Patrizia Della Valle; Armando D'Angelo; Luigi Naldini
Journal:  Blood       Date:  2007-08-28       Impact factor: 22.113

10.  Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain.

Authors:  Dominik F Aschauer; Sebastian Kreuz; Simon Rumpel
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more
  12 in total

1.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

Review 2.  Strategies for targeting primate neural circuits with viral vectors.

Authors:  Yasmine El-Shamayleh; Amy M Ni; Gregory D Horwitz
Journal:  J Neurophysiol       Date:  2016-04-06       Impact factor: 2.714

3.  Neuroprotection Induced by Transplanted CDK5 Knockdown Astrocytes in Global Cerebral Ischemic Rats.

Authors:  Andrea Becerra-Calixto; Gloria Patricia Cardona-Gómez
Journal:  Mol Neurobiol       Date:  2016-10-15       Impact factor: 5.590

Review 4.  Disentangling the Role of Astrocytes in Alcohol Use Disorder.

Authors:  Louise Adermark; M Scott Bowers
Journal:  Alcohol Clin Exp Res       Date:  2016-08-01       Impact factor: 3.455

Review 5.  Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Authors:  Chaitanya R Joshi; Vinod Labhasetwar; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-03       Impact factor: 4.147

Review 6.  The Role of Astrocytes in Neuroprotection after Brain Stroke: Potential in Cell Therapy.

Authors:  Andrea Becerra-Calixto; Gloria P Cardona-Gómez
Journal:  Front Mol Neurosci       Date:  2017-04-03       Impact factor: 5.639

Review 7.  Astrocytes: Role and Functions in Brain Pathologies.

Authors:  Rosalba Siracusa; Roberta Fusco; Salvatore Cuzzocrea
Journal:  Front Pharmacol       Date:  2019-09-27       Impact factor: 5.810

Review 8.  Sprouty2-a Novel Therapeutic Target in the Nervous System?

Authors:  Barbara Hausott; Lars Klimaschewski
Journal:  Mol Neurobiol       Date:  2018-09-17       Impact factor: 5.590

9.  A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain.

Authors:  Marine Droguerre; Tomokazu Tsurugizawa; Adeline Duchêne; Benjamin Portal; Bruno P Guiard; Nicole Déglon; Nathalie Rouach; Michel Hamon; Franck Mouthon; Luisa Ciobanu; Mathieu Charvériat
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

10.  Maximizing lentiviral vector gene transfer in the CNS.

Authors:  Morgane Humbel; Mergim Ramosaj; Virginie Zimmer; Sara Regio; Ludiwine Aeby; Sylvain Moser; Alexia Boizot; Mélanie Sipion; Maria Rey; Nicole Déglon
Journal:  Gene Ther       Date:  2020-07-06       Impact factor: 4.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.